Conmed Corp (CNMD): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$25.86M
As of 2019-12-31
-1.9%
3-year compound annual growth
-17.2%
5-year compound annual growth
+9.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2019-12-31 | $25.86M | +47.7% | 2020-02-24, Balance as of period end |
| 2018-12-31 | $17.51M | -46.3% | 2020-02-24, Balance as of period end |
| 2017-12-31 | $32.62M | +18.9% | 2020-02-24, Balance as of period end |
| 2016-12-31 | $27.43M | -62.2% | 2019-02-25, Balance as of period end |
| 2015-12-31 | $72.50M | +9.3% | 2018-02-26, Balance as of period end |
| 2014-12-31 | $66.33M | +21.8% | 2017-02-27, Balance as of period end |
| 2013-12-31 | $54.44M | +129.5% | 2016-02-23, Balance as of period end |
| 2012-12-31 | $23.72M | -8.9% | 2015-02-23, Balance as of period end |
| 2011-12-31 | $26.05M | +109.8% | 2014-02-24, Balance as of period end |
| 2010-12-31 | $12.42M | +23.0% | 2013-02-25, Balance as of period end |
| 2009-12-31 | $10.10M | n/a | 2012-02-28, Balance as of period end |